MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 7, 2006; DOI: 10.1124/mol.106.028597


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.028597v1
71/2/539    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCartney, M. R
Right arrow Articles by Hales, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCartney, M. R
Right arrow Articles by Hales, T. G.


Received for publication July 6, 2006.
Revised November 6, 2006.
Accepted for publication November 7, 2006.

Tonically active GABAA receptors in hippocampal pyramidal neurons exhibit constitutive GABA-independent gating

Melissa R McCartney 1, Tarek Z Deeb 1, Tricia N Henderson 1, Tim G. Hales 1*

1 George Washington University Medical Center

* Address correspondence to: E-mail: phmtgh{at}gwumc.edu

Abstract

Phasic and tonic inhibitory currents of hippocampal pyramidal neurons exhibit distinct pharmacological properties. Picrotoxin and bicuculline methiodide inhibited both components, consistent with a role for GABAA receptors, however, gabazine, at a concentration that abolished mIPSCs and responses to exogenous GABA, had no effect on tonic currents. Since all GABA-activated GABAA receptors in pyramidal neurons are gabazine sensitive it follows that tonic currents are not GABA-activated. Furthermore, picrotoxin-sensitive spontaneous single channel events recorded from outside-out patches had the same chord conductance as GABA-activated channels and were gabazine resistant. Therefore we hypothesize that GABAA receptors, constitutively active in the absence of GABA, mediate tonic current; the failure of gabazine to block tonic current reflects a lack of negative intrinsic efficacy of the antagonist. We compared the negative efficacies of bicuculline and gabazine using the general anesthetic propofol to directly activate GABAA receptors native to pyramidal neurons or {alpha}1{beta}3{gamma}2 receptors recombinantly expressed in HEK293 cells. Propofol activated gabazine-resistant, bicuculline-sensitive currents when applied to either preparation. While gabazine had negligible efficacy as an inhibitor of propofol-activated currents, it prevented inhibition by bicuculline, which acts as an inverse agonist inhibiting GABA-independent gating. Recombinant {alpha}1{beta}1/3{gamma}2 receptors also mediated agonist-independent tonic currents that were resistant to gabazine and inhibited by bicuculline. Thus gabazine is a competitive antagonist with negligible negative efficacy and is therefore unable to inhibit GABAA receptors that are active in the absence of GABA, due to either anesthetic or spontaneous gating. Moreover, spontaneously active GABAA receptors mediate gabazine resistant tonic currents in pyramidal neurons.


Key words: GABAA, GABAC, Glycine, Barbiturates, Benzodiazepines, Gases/general anesthetics


This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
E. I. Krook-Magnuson, P. Li, S. M. Paluszkiewicz, and M. M. Huntsman
Tonically Active Inhibition Selectively Controls Feedforward Circuits in Mouse Barrel Cortex
J Neurophysiol, August 1, 2008; 100(2): 932 - 944.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Janssens, M. Boussemaere, S. Wagner, K. Kopka, and C. Denef
{beta}1-Adrenoceptors in Rat Anterior Pituitary May Be Constitutively Active. Inverse Agonism of CGP 20712A on Basal 3',5'-Cyclic Adenosine 5'-Monophosphate Levels
Endocrinology, May 1, 2008; 149(5): 2391 - 2402.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. P. Goodkin, S. Joshi, Z. Mtchedlishvili, J. Brar, and J. Kapur
Subunit-Specific Trafficking of GABAA Receptors during Status Epilepticus
J. Neurosci., March 5, 2008; 28(10): 2527 - 2538.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Glykys, E. O. Mann, and I. Mody
Which GABAA Receptor Subunits Are Necessary for Tonic Inhibition in the Hippocampus?
J. Neurosci., February 6, 2008; 28(6): 1421 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. C. Tjen-A-Looi, P. Li, and J. C. Longhurst
Role of medullary GABA, opioids, and nociceptin in prolonged inhibition of cardiovascular sympathoexcitatory reflexes during electroacupuncture in cats
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3627 - H3635.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R. P. Bonin, L. J. Martin, J. F. MacDonald, and B. A. Orser
{alpha}5GABAA Receptors Regulate the Intrinsic Excitability of Mouse Hippocampal Pyramidal Neurons
J Neurophysiol, October 1, 2007; 98(4): 2244 - 2254.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C.-T. Wang, A. G. Blankenship, A. Anishchenko, J. Elstrott, M. Fikhman, S. Nakanishi, and M. B. Feller
GABAA Receptor-Mediated Signaling Alters the Structure of Spontaneous Activity in the Developing Retina
J. Neurosci., August 22, 2007; 27(34): 9130 - 9140.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. Marchionni, A. Omrani, and E. Cherubini
In the developing rat hippocampus a tonic GABAA-mediated conductance selectively enhances the glutamatergic drive of principal cells
J. Physiol., June 1, 2007; 581(2): 515 - 528.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics